Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Cervical cancer, human papillomavirus (HPV), and HPV vaccination: exploring gendered perspectives, knowledge, attitudes, and cultural taboos among Mexican American adults.

Morales-Campos DY, Snipes SA, Villarreal EK, Crocker LC, Guerrero A, Fernandez ME.

Ethn Health. 2018 Jul 12:1-19. doi: 10.1080/13557858.2018.1494821. [Epub ahead of print]

PMID:
29998738
2.

The Minnesota Multiphasic Personality Inventory-2-RF in Treatment-Seeking Veterans with History of Mild Traumatic Brain Injury.

Jurick SM, Crocker LD, Keller AV, Hoffman SN, Bomyea J, Jacobson MW, Jak AJ.

Arch Clin Neuropsychol. 2018 May 30. doi: 10.1093/arclin/acy048. [Epub ahead of print]

PMID:
29850866
3.

Mechanisms of Acquired Resistance to Trastuzumab Emtansine in Breast Cancer Cells.

Li G, Guo J, Shen BQ, Yadav DB, Sliwkowski MX, Crocker LM, Lacap JA, Phillips GDL.

Mol Cancer Ther. 2018 Jul;17(7):1441-1453. doi: 10.1158/1535-7163.MCT-17-0296. Epub 2018 Apr 25.

PMID:
29695635
4.

CTX-M ESBL-producing Enterobacteriaceae: estimated prevalence in adults in England in 2014.

McNulty CAM, Lecky DM, Xu-McCrae L, Nakiboneka-Ssenabulya D, Chung KT, Nichols T, Thomas HL, Thomas M, Alvarez-Buylla A, Turner K, Shabir S, Manzoor S, Smith S, Crocker L, Hawkey PM.

J Antimicrob Chemother. 2018 May 1;73(5):1368-1388. doi: 10.1093/jac/dky007.

5.

Pathways: patient-centred decision counselling for women at risk of cancer-related infertility: a protocol for a comparative effectiveness cluster randomised trial.

Woodard TL, Hoffman AS, Crocker LC, Holman DA, Hoffman DB, Ma J, Bassett RL Jr, Leal VB, Volk RJ.

BMJ Open. 2018 Feb 21;8(2):e019994. doi: 10.1136/bmjopen-2017-019994.

6.

An Anti-GDNF Family Receptor Alpha 1 (GFRA1) Antibody-Drug Conjugate for the Treatment of Hormone Receptor-Positive Breast Cancer.

Bhakta S, Crocker LM, Chen Y, Hazen M, Schutten MM, Li D, Kuijl C, Ohri R, Zhong F, Poon KA, Go MAT, Cheng E, Piskol R, Firestein R, Fourie-O'Donohue A, Kozak KR, Raab H, Hongo JA, Sampath D, Dennis MS, Scheller RH, Polakis P, Junutula JR.

Mol Cancer Ther. 2018 Mar;17(3):638-649. doi: 10.1158/1535-7163.MCT-17-0813. Epub 2017 Dec 27.

PMID:
29282299
7.

Corrigendum to "Pretreatment biomarkers predicting PTSD psychotherapy outcomes: A systematic review" [Neurosci. Biobehav. Rev. 75 (2017) 140-156].

Colvonen PJ, Glassman LH, Crocker LD, Buttner MM, Orff H, Schiehser DM, Norman SB, Afari N.

Neurosci Biobehav Rev. 2018 Jan;84:495. doi: 10.1016/j.neubiorev.2017.09.020. Epub 2017 Sep 23. No abstract available.

PMID:
28951017
8.

Single-Cell Dynamics Determines Response to CDK4/6 Inhibition in Triple-Negative Breast Cancer.

Asghar US, Barr AR, Cutts R, Beaney M, Babina I, Sampath D, Giltnane J, Lacap JA, Crocker L, Young A, Pearson A, Herrera-Abreu MT, Bakal C, Turner NC.

Clin Cancer Res. 2017 Sep 15;23(18):5561-5572. doi: 10.1158/1078-0432.CCR-17-0369. Epub 2017 Jun 12.

PMID:
28606920
9.

Contributions to Executive Dysfunction in Operation Enduring Freedom/Operation Iraqi Freedom Veterans With Posttraumatic Stress Disorder and History of Mild Traumatic Brain Injury.

Jurick SM, Crocker LD, Sanderson-Cimino M, Keller AV, Trenova LS, Boyd BL, Twamley EW, Rodgers CS, Schiehser DM, Aupperle RL, Jak AJ.

J Head Trauma Rehabil. 2018 Mar/Apr;33(2):E41-E52. doi: 10.1097/HTR.0000000000000313.

PMID:
28520663
10.

KRAS Allelic Imbalance Enhances Fitness and Modulates MAP Kinase Dependence in Cancer.

Burgess MR, Hwang E, Mroue R, Bielski CM, Wandler AM, Huang BJ, Firestone AJ, Young A, Lacap JA, Crocker L, Asthana S, Davis EM, Xu J, Akagi K, Le Beau MM, Li Q, Haley B, Stokoe D, Sampath D, Taylor BS, Evangelista M, Shannon K.

Cell. 2017 Feb 23;168(5):817-829.e15. doi: 10.1016/j.cell.2017.01.020. Epub 2017 Feb 16.

11.

Pretreatment biomarkers predicting PTSD psychotherapy outcomes: A systematic review.

Colvonen PJ, Glassman LH, Crocker LD, Buttner MM, Orff H, Schiehser DM, Norman SB, Afari N.

Neurosci Biobehav Rev. 2017 Apr;75:140-156. doi: 10.1016/j.neubiorev.2017.01.027. Epub 2017 Jan 28. Review. Erratum in: Neurosci Biobehav Rev. 2018 Jan;84:495.

PMID:
28143760
12.

Neurocognition in PTSD: Treatment Insights and Implications.

Jak AJ, Crocker LD, Aupperle RL, Clausen A, Bomyea J.

Curr Top Behav Neurosci. 2016 Dec 27. doi: 10.1007/7854_2016_62. [Epub ahead of print]

PMID:
28025811
13.

Postconcussive symptom overreporting in Iraq/Afghanistan Veterans with mild traumatic brain injury.

Jurick SM, Twamley EW, Crocker LD, Hays CC, Orff HJ, Golshan S, Jak AJ.

J Rehabil Res Dev. 2016;53(5):571-584. doi: 10.1682/JRRD.2015.05.0094.

14.

Resting-state functional connectivity differentiates anxious apprehension and anxious arousal.

Burdwood EN, Infantolino ZP, Crocker LD, Spielberg JM, Banich MT, Miller GA, Heller W.

Psychophysiology. 2016 Oct;53(10):1451-9. doi: 10.1111/psyp.12696. Epub 2016 Jul 12.

15.

Shame versus trauma-related guilt as mediators of the relationship between PTSD symptoms and aggression among returning veterans.

Crocker LD, Haller M, Norman SB, Angkaw AC.

Psychol Trauma. 2016 Jul;8(4):520-7. doi: 10.1037/tra0000151.

PMID:
27348068
16.

Income, neural executive processes, and preschool children's executive control.

Ruberry EJ, Lengua LJ, Crocker LH, Bruce J, Upshaw MB, Sommerville JA.

Dev Psychopathol. 2017 Feb;29(1):143-154. doi: 10.1017/S095457941600002X. Epub 2016 Jan 28.

PMID:
26817409
17.

Assessing Mixing Quality of a Copovidone-TPGS Hot Melt Extrusion Process with Atomic Force Microscopy and Differential Scanning Calorimetry.

Lamm MS, DiNunzio J, Khawaja NN, Crocker LS, Pecora A.

AAPS PharmSciTech. 2016 Feb;17(1):89-98. doi: 10.1208/s12249-015-0387-9. Epub 2015 Aug 18.

18.

Gender typicality in children's speech: A comparison of boys with and without gender identity disorder.

Munson B, Crocker L, Pierrehumbert JB, Owen-Anderson A, Zucker KJ.

J Acoust Soc Am. 2015 Apr;137(4):1995-2003. doi: 10.1121/1.4916202.

PMID:
25920850
19.

An Antibody-Drug Conjugate Directed against Lymphocyte Antigen 6 Complex, Locus E (LY6E) Provides Robust Tumor Killing in a Wide Range of Solid Tumor Malignancies.

Asundi J, Crocker L, Tremayne J, Chang P, Sakanaka C, Tanguay J, Spencer S, Chalasani S, Luis E, Gascoigne K, Desai R, Raja R, Friedman BA, Haverty PM, Polakis P, Firestein R.

Clin Cancer Res. 2015 Jul 15;21(14):3252-62. doi: 10.1158/1078-0432.CCR-15-0156. Epub 2015 Apr 10.

20.

An anti-B7-H4 antibody-drug conjugate for the treatment of breast cancer.

Leong SR, Liang WC, Wu Y, Crocker L, Cheng E, Sampath D, Ohri R, Raab H, Hass PE, Pham T, Firestein R, Li D, Schutten M, Stagg NJ, Ogasawara A, Koppada N, Roth L, Williams SP, Lee BC, Chalouni C, Peng I, DeVoss J, Tremayne J, Polakis P, Polson AG.

Mol Pharm. 2015 Jun 1;12(6):1717-29. doi: 10.1021/mp5007745. Epub 2015 Apr 23.

PMID:
25853436
21.

The tyrosine phosphatase PTPN14 (Pez) inhibits metastasis by altering protein trafficking.

Belle L, Ali N, Lonic A, Li X, Paltridge JL, Roslan S, Herrmann D, Conway JR, Gehling FK, Bert AG, Crocker LA, Tsykin A, Farshid G, Goodall GJ, Timpson P, Daly RJ, Khew-Goodall Y.

Sci Signal. 2015 Feb 17;8(364):ra18. doi: 10.1126/scisignal.2005547.

PMID:
25690013
22.

Interactive effects of trait and state affect on top-down control of attention.

Hur J, Miller GA, McDavitt JR, Spielberg JM, Crocker LD, Infantolino ZP, Towers DN, Warren SL, Heller W.

Soc Cogn Affect Neurosci. 2015 Aug;10(8):1128-36. doi: 10.1093/scan/nsu163. Epub 2015 Jan 1.

23.

Identification of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with no evidence of CYP3A4 time-dependent inhibition and improved aqueous solubility.

Zak M, Liederer BM, Sampath D, Yuen PW, Bair KW, Baumeister T, Buckmelter AJ, Clodfelter KH, Cheng E, Crocker L, Fu B, Han B, Li G, Ho YC, Lin J, Liu X, Ly J, O'Brien T, Reynolds DJ, Skelton N, Smith CC, Tay S, Wang W, Wang Z, Xiao Y, Zhang L, Zhao G, Zheng X, Dragovich PS.

Bioorg Med Chem Lett. 2015 Feb 1;25(3):529-41. doi: 10.1016/j.bmcl.2014.12.026. Epub 2014 Dec 17.

PMID:
25556090
24.

Physicochemical and formulation developability assessment for therapeutic peptide delivery--a primer.

Bak A, Leung D, Barrett SE, Forster S, Minnihan EC, Leithead AW, Cunningham J, Toussaint N, Crocker LS.

AAPS J. 2015 Jan;17(1):144-55. doi: 10.1208/s12248-014-9688-2. Epub 2014 Nov 15. Review.

25.

Structural basis for resistance to diverse classes of NAMPT inhibitors.

Wang W, Elkins K, Oh A, Ho YC, Wu J, Li H, Xiao Y, Kwong M, Coons M, Brillantes B, Cheng E, Crocker L, Dragovich PS, Sampath D, Zheng X, Bair KW, O'Brien T, Belmont LD.

PLoS One. 2014 Oct 6;9(10):e109366. doi: 10.1371/journal.pone.0109366. eCollection 2014.

26.

Amphiregulin and PTEN evoke a multimodal mechanism of acquired resistance to PI3K inhibition.

Edgar KA, Crocker L, Cheng E, Wagle MC, Wongchenko M, Yan Y, Wilson TR, Dompe N, Neve RM, Belvin M, Sampath D, Friedman LS, Wallin JJ.

Genes Cancer. 2014 Mar;5(3-4):113-26.

27.

Electrophysiological evidence of the time course of attentional bias in non-patients reporting symptoms of depression with and without co-occurring anxiety.

Sass SM, Heller W, Fisher JE, Silton RL, Stewart JL, Crocker LD, Edgar JC, Mimnaugh KJ, Miller GA.

Front Psychol. 2014 Apr 9;5:301. doi: 10.3389/fpsyg.2014.00301. eCollection 2014.

28.

Development of a liver-targeted siRNA delivery platform with a broad therapeutic window utilizing biodegradable polypeptide-based polymer conjugates.

Barrett SE, Burke RS, Abrams MT, Bason C, Busuek M, Carlini E, Carr BA, Crocker LS, Fan H, Garbaccio RM, Guidry EN, Heo JH, Howell BJ, Kemp EA, Kowtoniuk RA, Latham AH, Leone AM, Lyman M, Parmar RG, Patel M, Pechenov SY, Pei T, Pudvah NT, Raab C, Riley S, Sepp-Lorenzino L, Smith S, Soli ED, Staskiewicz S, Stern M, Truong Q, Vavrek M, Waldman JH, Walsh ES, Williams JM, Young S, Colletti SL.

J Control Release. 2014 Jun 10;183:124-37. doi: 10.1016/j.jconrel.2014.03.028. Epub 2014 Mar 21.

PMID:
24657948
29.

An in vivo evaluation of amphiphilic, biodegradable peptide copolymers as siRNA delivery agents.

Barrett SE, Abrams MT, Burke R, Carr BA, Crocker LS, Garbaccio RM, Howell BJ, Kemp EA, Kowtoniuk RA, Latham AH, Leander KR, Leone AM, Patel M, Pechenov S, Pudvah NT, Riley S, Sepp-Lorenzino L, Walsh ES, Williams JM, Colletti SL.

Int J Pharm. 2014 May 15;466(1-2):58-67. doi: 10.1016/j.ijpharm.2014.03.011. Epub 2014 Mar 5.

PMID:
24607208
30.

Atorvastatin inhibits CXCR7 induction to reduce macrophage migration.

Ma W, Liu Y, Wang C, Zhang L, Crocker L, Shen J.

Biochem Pharmacol. 2014 May 1;89(1):99-108. doi: 10.1016/j.bcp.2014.02.014. Epub 2014 Feb 28.

PMID:
24582769
31.

Fragment-based identification of amides derived from trans-2-(pyridin-3-yl)cyclopropanecarboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT).

Giannetti AM, Zheng X, Skelton NJ, Wang W, Bravo BJ, Bair KW, Baumeister T, Cheng E, Crocker L, Feng Y, Gunzner-Toste J, Ho YC, Hua R, Liederer BM, Liu Y, Ma X, O'Brien T, Oeh J, Sampath D, Shen Y, Wang C, Wang L, Wu H, Xiao Y, Yuen PW, Zak M, Zhao G, Zhao Q, Dragovich PS.

J Med Chem. 2014 Feb 13;57(3):770-92. doi: 10.1021/jm4015108. Epub 2014 Jan 22.

PMID:
24405419
32.

Anxiety type modulates immediate versus delayed engagement of attention-related brain regions.

Spielberg JM, De Leon AA, Bredemeier K, Heller W, Engels AS, Warren SL, Crocker LD, Sutton BP, Miller GA.

Brain Behav. 2013 Sep;3(5):532-51. doi: 10.1002/brb3.157. Epub 2013 Aug 1.

33.

Dual targeting of HER2-positive cancer with trastuzumab emtansine and pertuzumab: critical role for neuregulin blockade in antitumor response to combination therapy.

Phillips GD, Fields CT, Li G, Dowbenko D, Schaefer G, Miller K, Andre F, Burris HA 3rd, Albain KS, Harbeck N, Dieras V, Crivellari D, Fang L, Guardino E, Olsen SR, Crocker LM, Sliwkowski MX.

Clin Cancer Res. 2014 Jan 15;20(2):456-68. doi: 10.1158/1078-0432.CCR-13-0358. Epub 2013 Oct 4.

34.

Cortical organization of inhibition-related functions and modulation by psychopathology.

Warren SL, Crocker LD, Spielberg JM, Engels AS, Banich MT, Sutton BP, Miller GA, Heller W.

Front Hum Neurosci. 2013 Jun 13;7:271. doi: 10.3389/fnhum.2013.00271. eCollection 2013.

35.

Relationships among cognition, emotion, and motivation: implications for intervention and neuroplasticity in psychopathology.

Crocker LD, Heller W, Warren SL, O'Hare AJ, Infantolino ZP, Miller GA.

Front Hum Neurosci. 2013 Jun 11;7:261. doi: 10.3389/fnhum.2013.00261. eCollection 2013.

36.

Endosomolytic bioreducible poly(amido amine disulfide) polymer conjugates for the in vivo systemic delivery of siRNA therapeutics.

Parmar RG, Busuek M, Walsh ES, Leander KR, Howell BJ, Sepp-Lorenzino L, Kemp E, Crocker LS, Leone A, Kochansky CJ, Carr BA, Garbaccio RM, Colletti SL, Wang W.

Bioconjug Chem. 2013 Apr 17;24(4):640-7. doi: 10.1021/bc300600a. Epub 2013 Mar 25.

PMID:
23496378
37.

Blocking NRG1 and other ligand-mediated Her4 signaling enhances the magnitude and duration of the chemotherapeutic response of non-small cell lung cancer.

Hegde GV, de la Cruz CC, Chiu C, Alag N, Schaefer G, Crocker L, Ross S, Goldenberg D, Merchant M, Tien J, Shao L, Roth L, Tsai SP, Stawicki S, Jin Z, Wyatt SK, Carano RA, Zheng Y, Sweet-Cordero EA, Wu Y, Jackson EL.

Sci Transl Med. 2013 Feb 6;5(171):171ra18. doi: 10.1126/scitranslmed.3004438.

38.

Issues in localization of brain function: The case of lateralized frontal cortex in cognition, emotion, and psychopathology.

Miller GA, Crocker LD, Spielberg JM, Infantolino ZP, Heller W.

Front Integr Neurosci. 2013 Jan 30;7:2. doi: 10.3389/fnint.2013.00002. eCollection 2013.

39.

Neural mechanisms of attentional control differentiate trait and state negative affect.

Crocker LD, Heller W, Spielberg JM, Warren SL, Bredemeier K, Sutton BP, Banich MT, Miller GA.

Front Psychol. 2012 Aug 21;3:298. doi: 10.3389/fpsyg.2012.00298. eCollection 2012.

40.

A brain network instantiating approach and avoidance motivation.

Spielberg JM, Miller GA, Warren SL, Engels AS, Crocker LD, Banich MT, Sutton BP, Heller W.

Psychophysiology. 2012 Sep;49(9):1200-14. doi: 10.1111/j.1469-8986.2012.01443.x. Epub 2012 Jul 27.

41.

Trait motivation moderates neural activation associated with goal pursuit.

Spielberg JM, Miller GA, Warren SL, Engels AS, Crocker LD, Sutton BP, Heller W.

Cogn Affect Behav Neurosci. 2012 Jun;12(2):308-22. doi: 10.3758/s13415-012-0088-8.

42.

Emotion disrupts neural activity during selective attention in psychopathy.

Sadeh N, Spielberg JM, Heller W, Herrington JD, Engels AS, Warren SL, Crocker LD, Sutton BP, Miller GA.

Soc Cogn Affect Neurosci. 2013 Mar;8(3):235-46. doi: 10.1093/scan/nsr092. Epub 2011 Dec 29.

43.

Preclinical pharmacokinetics of MEHD7945A, a novel EGFR/HER3 dual-action antibody, and prediction of its human pharmacokinetics and efficacious clinical dose.

Kamath AV, Lu D, Gupta P, Jin D, Xiang H, Wong A, Leddy C, Crocker L, Schaefer G, Sliwkowski MX, Damico-Beyer LA.

Cancer Chemother Pharmacol. 2012 Apr;69(4):1063-9. doi: 10.1007/s00280-011-1806-6. Epub 2011 Dec 28.

PMID:
22203367
44.

Pediatric emergency mass critical care: focus on family-centered care.

Mason KE, Urbansky H, Crocker L, Connor M, Anderson MR, Kissoon N; Task Force for Pediatric Emergency Mass Critical Care.

Pediatr Crit Care Med. 2011 Nov;12(6 Suppl):S157-62. doi: 10.1097/PCC.0b013e318234a812.

PMID:
22067925
45.

A two-in-one antibody against HER3 and EGFR has superior inhibitory activity compared with monospecific antibodies.

Schaefer G, Haber L, Crocker LM, Shia S, Shao L, Dowbenko D, Totpal K, Wong A, Lee CV, Stawicki S, Clark R, Fields C, Lewis Phillips GD, Prell RA, Danilenko DM, Franke Y, Stephan JP, Hwang J, Wu Y, Bostrom J, Sliwkowski MX, Fuh G, Eigenbrot C.

Cancer Cell. 2011 Oct 18;20(4):472-86. doi: 10.1016/j.ccr.2011.09.003.

46.

Interaction of cholesterol-conjugated ionizable amino lipids with biomembranes: lipid polymorphism, structure-activity relationship, and implications for siRNA delivery.

Zhang J, Fan H, Levorse DA, Crocker LS.

Langmuir. 2011 Aug 2;27(15):9473-83. doi: 10.1021/la201464k. Epub 2011 Jun 29.

PMID:
21648950
47.

Effective siRNA delivery and target mRNA degradation using an amphipathic peptide to facilitate pH-dependent endosomal escape.

Bartz R, Fan H, Zhang J, Innocent N, Cherrin C, Beck SC, Pei Y, Momose A, Jadhav V, Tellers DM, Meng F, Crocker LS, Sepp-Lorenzino L, Barnett SF.

Biochem J. 2011 Apr 15;435(2):475-87. doi: 10.1042/BJ20101021.

PMID:
21265735
48.

Ionization behavior of amino lipids for siRNA delivery: determination of ionization constants, SAR, and the impact of lipid pKa on cationic lipid-biomembrane interactions.

Zhang J, Fan H, Levorse DA, Crocker LS.

Langmuir. 2011 Mar 1;27(5):1907-14. doi: 10.1021/la104590k. Epub 2011 Jan 20.

PMID:
21250743
49.

Superior in vivo efficacy of afucosylated trastuzumab in the treatment of HER2-amplified breast cancer.

Junttila TT, Parsons K, Olsson C, Lu Y, Xin Y, Theriault J, Crocker L, Pabonan O, Baginski T, Meng G, Totpal K, Kelley RF, Sliwkowski MX.

Cancer Res. 2010 Jun 1;70(11):4481-9. doi: 10.1158/0008-5472.CAN-09-3704. Epub 2010 May 18.

50.

Modeling the efficacy of trastuzumab-DM1, an antibody drug conjugate, in mice.

Jumbe NL, Xin Y, Leipold DD, Crocker L, Dugger D, Mai E, Sliwkowski MX, Fielder PJ, Tibbitts J.

J Pharmacokinet Pharmacodyn. 2010 Jun;37(3):221-42. doi: 10.1007/s10928-010-9156-2. Epub 2010 Apr 28.

PMID:
20424896

Supplemental Content

Loading ...
Support Center